HW
UTMD icon

Hancock Whitney’s Utah Medical Products UTMD Stock Holding History

Hancock Whitney’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,386
Closed -$319K – 874
2018
Q3 		$319K Buy
3,386
+40
+1% +$3.82K 0.01% 744
2018
Q2 		$369K Buy
3,346
+22
+0.7% +$2.3K 0.02% 465
2018
Q1 		$329K Buy
3,324
+387
+13% +$34.5K 0.01% 469
2017
Q4 		$239K Buy
2,937
+87
+3% +$6.79K 0.01% 533
2017
Q3 		$210K Buy
+2,850
New +$205K 0.01% 528

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Hancock Whitney's UTMD Position: Q4 2018 in Review

Hancock Whitney sold out of Utah Medical Products (UTMD) in Q4 2018, closing a stake of 3,386 shares — an estimated $319K sold.

Hancock Whitney first reported a position in UTMD in Q3 2017 and held it in 5 quarters. The position peaked at $369K in Q2 2018. 88 funds tracked by Wall St. Rank hold UTMD as of Q4 2018.

  • Hancock Whitney reported no remaining Utah Medical Products position as of Q4 2018 after selling out during the quarter.
  • Hancock Whitney sold 3,386 Utah Medical Products shares in Q4 2018, an estimated $319K.
  • Hancock Whitney first reported a position in Utah Medical Products in Q3 2017 and held it in 5 quarters.
  • Hancock Whitney's Utah Medical Products position peaked at $369K in Q2 2018.
  • 88 funds tracked by Wall St. Rank held Utah Medical Products as of Q4 2018.

Based on Hancock Whitney's 13F filing for Q4 2018, filed 15 Feb 2019.